| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01660620 | Development of Side Effects From Betaxolol | Drug: Betaxolol|Drug: topical betaxolol | Smith-Kettlewell Eye Research Institute|Ohio State University|University of Minnesota - Clinical and Translational Science Institute|University of Oklahoma|The University of Texas Health Science Center, Houston | Phase 1 | 2011-04-01 | 2013-01-02 |
| NCT00061542 | Glaucoma|Ocular Hypertension | Drug: BETOPTIC S (betaxolol HCl)|Drug: Timolol Gel-forming Solution (TGFS) | Alcon Research | Phase 3 | 2003-01-01 | 2016-11-16 |
| NCT02617459 | Primary Open-angle Glaucoma|Ocular Hypertension | Drug: Levobetaxolol eye drops|Drug: Betaxolol eye drops | Lee's Pharmaceutical Limited | Phase 3 | 2015-11-01 | 2015-11-30 |
| NCT00000132 | Open-Angle Glaucoma | Drug: Betaxolol|Procedure: Argon Laser Trabeculoplasty | National Eye Institute (NEI) | Phase 3 | 1992-10-01 | 2005-06-23 |
| NCT00684489 | Hypertension | Drug: clinical hypertension specialist-no specific med. Any anti-hypertension meds.|Drug: renin guided therapeutics-no specific med. Any anti-hypertensive med. | Medical University of South Carolina|New York Presbyterian Hospital | | 2003-09-01 | 2008-05-22 |
| NCT01316952 | Hypersensitivity | Drug: Carvedilol immediate release only|Drug: Carvedilol extended release only|Drug: Long acting blockers|Drug: Other adrenergic antagonists|Drug: Short acting Non-selective blockers and short acting 1-Selective agents|Other: No blocker | GlaxoSmithKline | | 2010-06-01 | 2015-04-14 |
